Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009
Gregory P. Giambrone1 , Shelley M. Zansky, Millicent Eidson, Pamela G. Duncan, Louise-Anne McNutt, and Guthrie S. Birkhead
Author affiliations: New York State Department of Health, Albany, New York, USA (G.P. Giambrone, S.M. Zansky, M. Eidson, P.G. Duncan, G.S. Birkhead); University at Albany School of Public Health, Rensselaer, New York, USA (L.-A. McNutt, G.S. Birkhead)
Figure. . Surveillance for Guillain-Barré syndrome during the A(H1N1)pdm09 National Influenza Vaccination Campaign, New York State, USA, October 1, 2009–may 31, 2010. SPARCS, Statewide Planning and Research Cooperative System.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.